Whey Protein Supplementation in Cancer Patients
Launched by FONDAZIONE IRCCS POLICLINICO SAN MATTEO DI PAVIA · Feb 17, 2014
Trial Information
Current as of June 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cancer patients (lung, gastric, pancreatic, breast, colon, esophageal)
- • Eastern Cooperative Oncology Group performance status ≤ 2
- • Weight loss \>= 10% in the last 6 months
- • Chemotherapy
- • Written informed consent
- Exclusion Criteria:
- • Age \< 18 years
- • Ongoing artificial nutrition (enteral or parenteral)
- • Unavailability to planned measurements
About Fondazione Irccs Policlinico San Matteo Di Pavia
Fondazione IRCCS Policlinico San Matteo di Pavia is a prestigious research hospital and clinical trial sponsor located in Italy, dedicated to advancing medical knowledge and improving patient care through innovative research. As a leading institution in the fields of clinical and translational medicine, the foundation actively conducts trials across various therapeutic areas, emphasizing rigorous scientific methodologies and adherence to ethical standards. With a commitment to fostering collaboration among healthcare professionals, researchers, and patients, Fondazione IRCCS Policlinico San Matteo serves as a pivotal contributor to the development of new treatments and healthcare solutions, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pavia, , Italy
Patients applied
Trial Officials
Emanuele Cereda, MD, PhD
Principal Investigator
1Nutrition and Dietetics Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Riccardo Caccialanza, MD
Study Director
1Nutrition and Dietetics Service, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials